Your session is about to expire
← Back to Search
Hypoxia Imaging Techniques for Liver Cancer
Study Summary
This trial is testing whether hypoxia can help predict the success of Y90 radioembolization for patients with liver cancer that has spread to a few sites.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to a few other parts of my body.I agree to use effective birth control during the study.I can take care of myself but might not be able to do heavy physical work.I have had treatments specifically aimed at liver tumors.I have another type of cancer besides the one in my liver.I am a woman capable of becoming pregnant.I am a woman who can have children and have a negative pregnancy test.My liver cancer is at an early to intermediate stage.My liver tumor is spreading into nearby tissues.I have a tumor that is at least 3 cm big.My liver cancer is in the most advanced stage.I am 18 years old or older.My liver cancer affects one or both lobes of my liver.My liver is expected to receive more than 30 Gy of radiation in one session.
- Group 1: Diagnostic (18F-fluoromisonidazole, PET, DCE MRI)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many volunteers are taking part in this clinical research?
"Affirmative. According to information on clinicaltrials.gov, this medical trial is actively recruiting participants since it was first posted in April 28th 2022 and last updated in May 25th 2022. A total of 20 patients are needed for the study at a single site."
Are there any available positions within this research study for participants?
"Affirmative. According to clinicaltrials.gov, this research initiative, which has been active since April 28th 2022, is actively recruiting patients. Currently they are looking for 20 individuals from a single medical site to take part in the study."
Share this study with friends
Copy Link
Messenger